Controlling medicine prices in Sudan: the challenge of the recently established Medicines Regulatory Authority.
- Published in:
- Eastern Mediterranean Health Journal, 2012, v. 18, n. 8, p. 811, doi. 10.26719/2012.18.8.811
- By:
- Publication type:
- Article
Works matching DE "DRUGS %26 economics"
Results: 928
1
2
Letter from the Editor.
- Published in:
- Eastern Mediterranean Health Journal, 2012, v. 18, n. 8, p. 795
- Publication type:
- Article
3
A Different View of the 340B Program.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 3, p. 178
- By:
- Publication type:
- Article
4
The 340b Drug Discount Program: Oncology's Optical Illusion.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 11, p. 1068
- By:
- Publication type:
- Article
5
Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries.
- Published in:
- 2020
- By:
- Publication type:
- journal article
6
Unmet medical needs in ambulatory care in Hungary: forgone visits and medications from a representative population survey.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Reimbursable drug classes and ceilings in Italy: why not only one?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
9
Price offers of pharmaceutical procurement in China: evidence from Guangdong province.
- Published in:
- 2016
- By:
- Publication type:
- journal article
10
Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
- Published in:
- 2015
- By:
- Publication type:
- journal article
11
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
12
Caregivers’ willingness-to-pay for Alzheimer’s disease medications in Canada.
- Published in:
- Dementia (14713012), 2015, v. 14, n. 1, p. 63, doi. 10.1177/1471301213490709
- By:
- Publication type:
- Article
13
Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA.
- Published in:
- Osteoporosis International, 2020, v. 31, n. 12, p. 2461, doi. 10.1007/s00198-020-05513-x
- By:
- Publication type:
- Article
14
Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 12, p. 1291, doi. 10.1007/s00228-011-1077-5
- By:
- Publication type:
- Article
15
Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia & Herzegovina.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 2, p. 177, doi. 10.1007/s00228-009-0732-6
- By:
- Publication type:
- Article
16
Public Perceptions, Expectations, and Views of Community Pharmacy Practice in Kuwait.
- Published in:
- 2017
- By:
- Publication type:
- journal article
17
An international, collaborative electronic elective course for medical students: economic and ...
- Published in:
- Medical Teacher, 1999, v. 21, n. 5, p. 485, doi. 10.1080/01421599979167
- By:
- Publication type:
- Article
18
Impact of removing prescription co-payments on the use of costly health services: A pragmatic randomised controlled trial.
- Published in:
- Pharmacy Research Review, 2023, n. 84, p. 1
- By:
- Publication type:
- Article
19
Analysis of medicines returned to pharmacies for disposal and estimation of the cost due to medicine wasting.
- Published in:
- Pharmacy Research Review, 2022, n. 79, p. 3
- By:
- Publication type:
- Article
20
Medication savings for the NHS and for patients.
- Published in:
- British Journal of Community Nursing, 2022, v. 27, n. 12, p. 578, doi. 10.12968/bjcn.2022.27.12.578
- By:
- Publication type:
- Article
21
Benefits of nurse-led continence prescription services for effective stock management and streamlined prescribing.
- Published in:
- British Journal of Community Nursing, 2019, v. 24, n. 9, p. 424, doi. 10.12968/bjcn.2019.24.9.424
- By:
- Publication type:
- Article
22
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members.
- Published in:
- 2021
- By:
- Publication type:
- journal article
23
A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care.
- Published in:
- 2020
- By:
- Publication type:
- journal article
24
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.
- Published in:
- 2018
- By:
- Publication type:
- journal article
25
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
26
Determinants of Market Exclusivity for Prescription Drugs in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
27
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
- Published in:
- 2016
- By:
- Publication type:
- journal article
28
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
- Published in:
- 2016
- By:
- Publication type:
- journal article
29
Diabetes management gains: teaching old dogs new tricks.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 9, p. 1072, doi. 10.1111/dme.14068
- By:
- Publication type:
- Article
30
Treatment of Type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 1, p. 120, doi. 10.1111/dme.13193
- By:
- Publication type:
- Article
31
Societal costs of diabetes mellitus in Denmark.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 7, p. 877, doi. 10.1111/dme.12965
- By:
- Publication type:
- Article
32
US-Based Drug Cost Parameter Estimation for Economic Evaluations.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
33
Opportunity Cost of Funding Drugs for Rare Diseases: The Cost-Effectiveness of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
34
Electronic Notifications about Drug Substitutes Can Change Physician Prescription Habits: A Cross-Sectional Observational Study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
35
Cost-Effectiveness Analysis: Discount the Placebo at Your Peril.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
36
Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
- Published in:
- 2020
- By:
- Publication type:
- journal article
37
Emergency department visits by pediatric patients for poisoning by prescription opioids.
- Published in:
- 2016
- By:
- Publication type:
- journal article
38
The Impact of Shortages on Medication Prices: Implications for Shortage Prevention.
- Published in:
- Drugs, 2016, v. 76, n. 16, p. 1551, doi. 10.1007/s40265-016-0651-7
- By:
- Publication type:
- Article
39
Ethnographic Insights into the Quality of Life and Experiences of People Living with Schizophrenia in Harare, Zimbabwe.
- Published in:
- Issues in Mental Health Nursing, 2021, v. 42, n. 1, p. 65, doi. 10.1080/01612840.2020.1770385
- By:
- Publication type:
- Article
40
Understanding the Experience and Perspectives of Parkinson's Disease Patients' Caregivers.
- Published in:
- Rehabilitation Research & Practice, 2019, p. 1, doi. 10.1155/2019/3082325
- By:
- Publication type:
- Article
41
The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus.
- Published in:
- Healthcare Policy, 2020, v. 16, n. 2, p. 82, doi. 10.12927/hcpol.2020.26351
- By:
- Publication type:
- Article
42
Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study.
- Published in:
- Healthcare Policy, 2019, v. 14, n. 3, p. 10
- By:
- Publication type:
- Article
43
Ontario and New Zealand Pharmaceuticals: Cost and Coverage.
- Published in:
- Healthcare Policy, 2018, v. 13, n. 4, p. 23
- By:
- Publication type:
- Article
44
The Pharmaceutical Industry and the Canadian Government: Folie à Deux.
- Published in:
- Healthcare Policy, 2017, v. 13, n. 1, p. 10
- By:
- Publication type:
- Article
45
Is Canadian Healthcare Affordable? A Comparative Analysis of the Canadian Healthcare System from 2004 to 2014.
- Published in:
- Healthcare Policy, 2017, v. 13, n. 1, p. 43
- By:
- Publication type:
- Article
46
Estimating the Cost of Cancer Care in British Columbia and Ontario: A Canadian Inter-Provincial Comparison.
- Published in:
- Healthcare Policy, 2017, v. 12, n. 3, p. 94
- By:
- Publication type:
- Article
47
Identifying Distinct Geographic Health Service Environments in British Columbia, Canada: Cluster Analysis of Population-Based Administrative Data.
- Published in:
- Healthcare Policy, 2016, v. 12, n. 1, p. 43
- By:
- Publication type:
- Article
48
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.
- Published in:
- Healthcare Policy, 2016, v. 12, n. 1, p. 18
- By:
- Publication type:
- Article
49
The impact of alternative pricing methods for drugs in California Workers’ Compensation System: Fee-schedule pricing.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197449
- By:
- Publication type:
- Article
50
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia.
- Published in:
- Pan American Journal of Public Health, 2008, v. 24, n. 4, p. 233
- By:
- Publication type:
- Article